The FDA has approved safety labeling revisions for risedronate sodium tablets, human papillomavirus quadrivalent [recombinant] vaccine, and mycophenolic acid delayed-release tablets. Medscape Medical News
No Comments »
Filed under: General Health News
CDC guidelines calling for general rather than specific consent for HIV testing and optional rather than mandatory prevention counseling raise more concerns among physicians than patients. Medscape Medical News
No Comments »
Filed under: General Health News
People at risk for autoimmune disease are especially susceptible to the detrimental effects of smoking, but a new study suggests that nicotine might not be the culprit. Medscape Medical News
No Comments »
Filed under: General Health News
Diet may affect the way a pilot performs on the job, a randomized, crossover trial showed.
No Comments »
Filed under: General Health News
Prazosin, a drug originally introduced to lower blood pressure and subsequently used for benign prostatic hyperplasia, appears to be effective for reducing debilitating trauma nightmares in soldiers deployed to Iraq, a small, open-label study showed.
No Comments »
Filed under: General Health News
Pfizer will pay the government $2.3 billion to settle criminal and civil charges that it promoted off-label uses for the disgraced painkiller valdecoxib (Bextra) and three other drugs.
No Comments »
Filed under: Pharmacy News
Low doses of an investigational, delayed-release version of prednisone relieved rheumatoid arthritis symptoms in a pivotal phase III trial, paving the way for a U.S. marketing application, the product’s manufacturer said.
No Comments »
Filed under: Pharmacy News
WASHINGTON (MedPage Today) — An FDA advisory panel recommended that randomized, controlled trials be required before the agency approves two drugs to treat acute myeloid leukemia, clofarabine (Clolar) and laromustine (Onrigin).
No Comments »
Filed under: Pharmacy News
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, and muscle, today announced preliminary results from the ACE-031 Phase 1 single dose clinical trial indicating that ACE-031 was safe and well-tolerated at all dose levels and increased lean body mass.
No Comments »
Filed under: Pharmacy News
The U.S. Food and Drug Administration (FDA) has approved Astepro (azelastine) nasal spray 0.15% for the treatment of the symptoms of seasonal and perennial allergic rhinitis.
No Comments »
Filed under: Pharmacy News
